Add Yahoo as a preferred source to see more of our stories on Google. Learn more about the benefits and risks of taking Lovenox during pregnancy. While most pregnancies progress smoothly and without ...
February 17, 2010 (Paris, France) — A new-point-of care test that can be used in the cath lab to monitor anticoagulation levels of enoxaparin (Lovenox, Sanofi-Aventis) has been shown to give reliable ...
A more selective risk-stratified approach to postpartum enoxaparin (Lovenox) thromboprophylaxis for venous thromboembolism (VTE) was linked to reduced rates of wound hematomas without increasing the ...
PARIS, May 18 (Reuters) - Sanofi-Aventis has won U.S. health authority clearance to use its bloodthinner Lovenox in patients who suffer from the most severe type of heart attack, the French drugmaker ...
"Is this the end of UFH? We continue to have more and more evidence suggesting better and safer outcomes with low-molecular-weight heparin, and we as interventionalists should pay attention to this." ...
LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results